Literature DB >> 17679095

Structural basis for ubiquitin-mediated dimerization and activation of the ubiquitin protein ligase Cbl-b.

Pascal Peschard1, Guennadi Kozlov, Tong Lin, I Ahmad Mirza, Albert M Berghuis, Stanley Lipkowitz, Morag Park, Kalle Gehring.   

Abstract

Cbl proteins are E3 ubiquitin ligases that are negative regulators of many receptor tyrosine kinases. Cbl-b and c-Cbl contain a ubiquitin-associated (UBA) domain, which is present in a variety of proteins involved in ubiquitin-mediated processes. Despite high sequence identity, Cbl UBA domains display remarkably different ubiquitin-binding properties. Here, we report the crystal structure of the UBA domain of Cbl-b in complex with ubiquitin at 1.9 A resolution. The structure reveals an atypical mechanism of ubiquitin recognition by the first helix of the UBA. Helices 2 and 3 of the UBA domain form a second binding surface, which mediates UBA dimerization in the crystal and in solution. Site-directed mutagenesis demonstrates that Cbl-b dimerization is regulated by ubiquitin binding and required for tyrosine phosphorylation of Cbl-b and ubiquitination of Cbl-b substrates. These studies demonstrate a role for ubiquitin in regulating biological activity by promoting protein dimerization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17679095     DOI: 10.1016/j.molcel.2007.06.023

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  50 in total

1.  Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl.

Authors:  Hao Dou; Lori Buetow; Andreas Hock; Gary J Sibbet; Karen H Vousden; Danny T Huang
Journal:  Nat Struct Mol Biol       Date:  2012-01-22       Impact factor: 15.369

2.  A helical conotoxin from Conus imperialis has a novel cysteine framework and defines a new superfamily.

Authors:  Mingyu Ye; Keith K Khoo; Shaoqiong Xu; Mi Zhou; Nonlawat Boonyalai; Matthew A Perugini; Xiaoxia Shao; Chengwu Chi; Charles A Galea; Chunguang Wang; Raymond S Norton
Journal:  J Biol Chem       Date:  2012-03-07       Impact factor: 5.157

3.  An E2 accessory domain increases affinity for the anaphase-promoting complex and ensures E2 competition.

Authors:  Juliet R Girard; Jeanette L Tenthorey; David O Morgan
Journal:  J Biol Chem       Date:  2015-08-25       Impact factor: 5.157

Review 4.  Degradation of activated protein kinases by ubiquitination.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

5.  Distinct recruitment of Eps15 via Its coiled-coil domain is required for efficient down-regulation of the met receptor tyrosine kinase.

Authors:  Christine A Parachoniak; Morag Park
Journal:  J Biol Chem       Date:  2008-12-24       Impact factor: 5.157

Review 6.  Cbl- and Nedd4-family ubiquitin ligases: balancing tolerance and immunity.

Authors:  Denise L Gay; Hilda Ramón; Paula M Oliver
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 7.  Viewing protein fitness landscapes through a next-gen lens.

Authors:  Jeffrey I Boucher; Pamela Cote; Julia Flynn; Li Jiang; Aneth Laban; Parul Mishra; Benjamin P Roscoe; Daniel N A Bolon
Journal:  Genetics       Date:  2014-10       Impact factor: 4.562

8.  Met kinase-dependent loss of the E3 ligase Cbl in gastric cancer.

Authors:  Andrea Z Lai; Michael Durrant; Dongmei Zuo; Colin D H Ratcliffe; Morag Park
Journal:  J Biol Chem       Date:  2012-01-18       Impact factor: 5.157

9.  Multiple Weak Linear Motifs Enhance Recruitment and Processivity in SPOP-Mediated Substrate Ubiquitination.

Authors:  Wendy K Pierce; Christy R Grace; Jihun Lee; Amanda Nourse; Melissa R Marzahn; Edmond R Watson; Anthony A High; Junmin Peng; Brenda A Schulman; Tanja Mittag
Journal:  J Mol Biol       Date:  2015-10-22       Impact factor: 5.469

10.  Avid interactions underlie the Lys63-linked polyubiquitin binding specificities observed for UBA domains.

Authors:  Joshua J Sims; Aydin Haririnia; Bryan C Dickinson; David Fushman; Robert E Cohen
Journal:  Nat Struct Mol Biol       Date:  2009-07-20       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.